How do the currently used prophylactic agents work in migraine?

Cephalalgia

Volumn 17, Issue 2, 1997, Pages 85-92

  Goadsby, P J ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; FLUNARIZINE; IMIPRAMINE; METHYSERGIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; PIZOTIFEN; PROPRANOLOL; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SODIUM CHANNEL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID; WAY 100165;

BRAIN BLOOD FLOW; CLINICAL TRIAL; EPILEPTIC AURA; EXTRAVASATION; HUMAN; MIGRAINE; NONHUMAN; PROPHYLAXIS; REVIEW; SEROTONINERGIC SYSTEM; SPREADING CORTICAL DEPRESSION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; MIGRAINE DISORDERS; SEROTONIN ANTAGONISTS;

EID: 0030904915     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1702085.x     Document Type: Review

References (91)

1. Goadsby PJ. The challenge of headache for the nineties. Curr Opin Neurol 1994;7:255-82
2. Goadsby PJ, Silberstein SD. Headache. New York: Butterworth-Heinemann, 1997
3. Catarci T, Rose FC. Migraine and heredity. Pathologie et Biologie (Paris) 1992;40:284-6
4. Joutel A, Bousser MG, Biousse V, et al. A gene for familial hemiplegic migraine maps to chromosome 19, Nat Gen 1993;5:40-5
5. Montagna P, Gallassi R, Medori R, et al. MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology 1988;38:751-4
6. Koo B, Becker LE, Chuang S, et al. Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): clinical, radiological, pathological and genetic observations. Ann Neurol 1993:34
7. Uncini A, Lodi R, Di Muzio A, et al. Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J Neurol Sci 1995;129:214-22
8. Crimmins D, Morris JG, Walker GL, et al. Mitochondrial encephalomyopathy: variable clinical expression within a single kindred. J Neurol Neurosurg Psychiatry 1993;56:900-5
9. Ducros A, Joutel A, Vahedi K, et al. Towards the identification of a second locus for familial hemiplegic migraine. Cephalalgia 1995;15 Suppl 14:9
10. Terwindt GM, Ophoff RA, May A, et al. Familial hemiplegic migraine locus on 19P13 is involved in the common forms of migraine with and without aura. Cephalalgia 1995;15 Suppl 14:8
11. Russell MB, Andersson PG, Thomsen LL, Iselius L. Cluster headache is an autosomal dominantly inherited disorder in some families: a complex segregation analysis. J Med Genet 1995;32:954-6
12. Griggs RC, Nutt JG. Episodic ataxias as channelopathies. Ann Neurol 1995;37:285-7
13. Goadsby PJ, Boyce G. Paroxysmal cerebellar ataxia. Aust NZ J Med 1990;20:103
14. Vahedi K, Joutel A, van Bogaert P, et al. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol 1995;37:289-93
15. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972;22:355-65
16. Kupfermann I. Hypothalamus and limbic system II: motivation. In: Kandel ER, Schwartz JH, editors. Principles of neural science. Amsterdam Science Publishers: Elsevier, 1985: 626-35
17. Swaab DF, Hofman MA, Lucassen PJ, Purba JS, Raadsheer FC, van de Nes JA. Functional neuroanatomy and neuropathology of the hypothalamus. Anat Embryol 1993;187:317-30
18. Moore-Ede MC. The circadian timing system in mammals: two pacemakers preside over many secondary oscillators. Fed Proc 1983;42:2802-8
19. Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-92
20. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994;117:199-210
21. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-52
22. Lauritzen M, Skyhøj-Olsen T, Lassen NA, Paulson OB. The changes of regional cerebral blood flow during the course of classical migraine attacks. Ann Neurol 1983;13:633-41
23. Lashley KS. Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 1941:46;331-9
24. Leao AAP. Spreading depression of activity in cerebral cortex. J Neurophysiol 1944;7:359-90
25. Leao AAP. Pial circulation and spreading activity in the cerebral cortex. J Neurophysiol 1944;7:391-6
26. Leao AAP. Further observations on the spreading depression of activity in the cerebral cortex. J Neurophysiol 1947;10:409-14
27. Marshall WH. Spreading cortical depression of Leao. Physiol Rev 1959;39:239-88
28. Friberg L, Skyhøj-Olsen T, Roland PE, Lassen NA. Focal ischaemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine. Brain 1987;110:917-34
29. Simard D, Paulson OB. Cerebral vasomotor paralysis during migraine attack. Arch Neurol 1973;29:207-9
30. Sakai F, Meyer JS. Abnormal cerebrovascular reactivity in patients with migraine and cluster headache. Headache 1979;19:257-66
31. Lauritzen M, Skyhøj-Olsen T, Lassen NA, Paulson OB. Regulation of regional cerebral blood flow during and between migraine attacks. Ann Neurol 1983;14:569-72
32. Peatfield RC, Rose FC. Prospective study of unilateral classical migraine. In: Rose FC, editor. New advances in headache research: 2. London: Smith-Gordon, 1991:35-8
33. Olesen J, Friberg L, Skyhøj-Olsen, et al. Timing and topography of cerebral blood flow, aura and headache during migraine attacks. Ann Neurol 1990;28:791-8
34. Kraig RP, Nicholson C. Extracellular ionic variations during spreading depression. Neuroscience 1978;3:1045-59
35. Lauritzen M, Jørgensen MB, Diemer NH, Gjedde A, Hansen AJ. Persistent oligaemia of rat cerebral cortex in the wake of spreading depression. Ann Neurol 1982;12:469-74
36. Sramka M, Brozek G, Bures J, Nadvornik P. Functional ablation by spreading depression: possible use in human stereotactic neurosurgery. Appl Neurophysiol 1977;40:48-61
37. 14C]-iodo-antipyrine techniques. J Cereb Blood Flow Metab 1989;9:79-86
38. Hansen AJ, Quistorff B, Gjedde A. Relationship between local changes in cortical blood flow and extracellular K+ during spreading depression. Acta Physiol Scand 1980;109:1-6
39. 2 response. J Cereb Blood Flow Metab 1984;4:546-54
40. Mraovitch S, Calando Y, Seylaz J. Long-lasting cerebral blood flow and metabolic changes within the limbic and brainstem regions following cortical spreading depression in rat. J Cereb Blood Flow Metab 1989;9:S508
41. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterising cerebrovascular and neuropeptide changes seen in man and cat. Ann Neurol 1993;33:48-56
42. Goadsby PJ, Seylaz J, Mraovitch S. Hypercapnic but not neurogenic cortical vasodilatation is blocked by spreading depression in rat. In: Olesen J editor. Migraine and other headaches. The vascular mechanisms, vol. 1. 1991:181-6
43. Brindley GS, Lewin WS. The sensations produced by electrical stimulation of the visual cortex. J Physiol 1968;196:479-93
44. Penfield W, Perot P. The brain's record of auditory and visual experience. Brain 1963;86:595-696
45. Hubel DH, Weisel TN. Receptive fields and functional architecture of monkey striate cortex. J Physiol 1968;195:215-43
46. Welch KMA, D'Andrea G, Tepley N, Barkeley GL, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Headache 1990;8(4):817-28
47. Piper RD, Matheson JM, Hellier M, et al. Cortical spreading depression is not seen intraoperatively during temporal lobectomy in humans. Cephalalgia 1991;11 Suppl 11:1
48. McLachlan RS, Girvin JP. Spreading depression of Leao in rodent and human cortex. Brain Res 1994;666:133-6
49. Kaube H, Goadsby PJ. Antimigraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur Neurol 1994;34:30-5
50. Scharff L, Turk DC, Marcus DA. Triggers of headache episodes and coping responses of headache diagnostic groups. Headache 1995;35:397-403
51. Glover V, Peatfield R, Zammit-Pace R, et al. Platelet monoamine oxidase activity and headache. J Neurol Neurosurg Psychiatry 1981;44:786-90
52. Littlewood J, Glover V, Sandler M. Platelet phenolsulphotransferase deficiency in dietary migraine. Lancet 1982;1:983-5
53. Rein G, Glover V, Sandler M. Multiple forms of phenolsulphotransferase in human tissues: selective inhibition by dichloronitrophenol. Biochem Pharmacol 1982;31:1893-7
54. Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994;46:157-203
55. Curran DA, Hinterberger H, Lance JW. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain 1965;88:997-1010
56. Anthony M, Hinterberger H, Lance JW. Plasma serotonin in migraine and stress. Arch Neurol 1967;16:544-52
57. Kimball RW, Friedman AP, Vallejo E. Effect of serotonin in migraine patients. Neurology (Minneap) 1960;10:107-11
58. Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 1991;44:97-112
59. Kahn RS, Wetzler S. m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 1991;30:1139-66
60. Brewerton TD, Murphy DL, Mueller EA, Jimerson DC. Induction of migraine like headaches by the serotonin agonist m-chlorophenylpiperazine. Clin Pharmacol Therap 1988;43: 605-9
61. Brewerton TD, Murphy DL, Lesern MD, Brandt HA, Jimerson DC. Headache responses following m-chlorophenylpiperazine in bulimics and controls. Headache 1992;32:217-22
62. 1c receptor activation: a key step in the initiation of migraine? Trends Pharmacol Sci 1989;10:307-9
63. Foguet M, Hoyer D, Pardo LA, et al. Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J 1992;11:3481-7
64. 2C receptor blockade? Life Sci 1994;54:641-4
65. Fozard JR, Kalkman HO. 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn-Schmiedeberg's Arch Pharmacol 1994;350:225-9
66. Winther K. Ketanserin - a selective serotonin antagonist, in relation to platelet aggregation and migraine attack rate. Cephalalgia 1985;5 Suppl 3:402-3
67. Stensrud P, Sjaastad O. Short-term clinical trial of propranolol in racemic form (Inderal), D-propranolol and placebo in migraine. Acta Neurol Scand 1976;53:229-32
68. 1C receptors and their therapeutic relevance. Curr Opin Invest Drugs 1993;2:317-62
69. +-ATPase in the choroid plexus. J Biol Chem 1995;270:2427-30
70. Hering R, Keritsky A. Sodium valproate in the prophylactic treatment of migraine: a double blind study versus placebo. Cephalalgia 1992;12:81-4
71. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple blind, placebo-controlled crossover study. Neurology 1994;44:647-51
72. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol 1995;52:281-6
73. Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia 1989;9: 195-8
74. Mueller EA, Murphy DL, Sunderland T. Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist in humans. 1985;61:1179-84
75. Hering R, Gilad I, Laron Z, Kuritzky A. Effect of sodium valproate on the secretion of prolactin, cortisol and growth hormone in migraine patients. Cephalalgia 1992;12:257-8
76. Cramer CL, Stagnitto ML, Knowles MA, Palmer GC. Kainic acid and 4-aminopyridine seizure models in mice: evaluation of efficacy of anti-epileptic agents and calcium antagonists. Life Sci 1994;54:271-5
77. Franceschetti S, Hamon B, Heinemann U. The action of valproate of spontaneous epileptiform activity in the absence of synaptic transmission and on evoked changes in [Ca2+]o and [K+]o in the hippocampal slice. Brain Res 1986;386:1-11
78. Van den Berg RJ, Kok P, Voskuyl RA. Valproate and sodium currents in cultured hippocampal neurons. Exp Brain Res 1993;93:279-87
79. + reactivation in Myxicola. Eur J Pharmacol 1987;138:89-93
80. Walden J, Altrup U, Reith H, Speckmann EJ. Effects of valproate on early and late potassium currents of single neurons. Eur Neuropsychopharmacol 1993;3:137-41
81. van Erp MG, van Dongen MG, van den Berg RJ. Voltage-dependent action of valproate on potassium channels in frog node of Ranvier. Eur J Pharmacol 1990;184:151-61
82. van Dongen AM, van Erp MG, Voskuyl RA. Valproate reduces excitability by blockage of sodium and potassium conductance. Epilepsia 1986;27:177-82
83. Goadsby PJ, Zagami AS, Lambert GA. Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache 1991;31:365-71
84. Geer JJ, Dooley DJ, Adams ME. K(+)-stimulated 45Ca2+ flux into rat neocortical mini-slices is blocked by omega-Aga-IVA and the dual Na+/Ca2+ channel blockers lidoflazine and flunarizine. Neurosci Lett 1993;158:97-100
85. 2+ channel gene CACNLA4. Cell Tiss Res 1996;87:543-52
86. Saper JR, Silberstein SD, Lake AE, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994;34:497-502
87. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nature Med 1995;1: 658-60
88. Fromm GH, Nakata M, Kondo T. Differential action of amitriptyline on neurons in trigeminal nucleus. Neurology 1991;41:1932-6
89. Hartig PR, Hoyer D, Humphrey PPA, Martin GR. Alignment of receptor nomenclature with the human genome: classification of 5HT-1B and 5-HT1D receptor subtypes. Trends Pharmacol Sci 1996;17:103-5
90. Lee WS, Moskowitz MA. Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638, exhibit enhanced potency against neurogenic inflammation in dura mater. Brain Res 1993;626:303-5
91. 1D receptor agonist MK-462. Cephalalgia 1995;15 Suppl 14:203